Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TJ0R
|
|||
| Former ID |
DIB000399
|
|||
| Drug Name |
TA-CIN
|
|||
| Synonyms |
HPV vaccine (cervical dysplasia), Xenova; HPV vaccines (cervical dysplasia), Cancer Research Technology; TA-CIN, Cancer Research Technology; TA-CIN, Xenova; HPV16 proteins L2/E6/E7, Cancer Research Technology; HPV16 proteins L2/E6/E7, Xenova; TA-HPV/TA-CIN); HPV-16 + NAX-57, Cancer Research Technology; HPV-16 + NAX-57, Cantab; HPV-16 + NAX-57, Xenova; TA-HPV/TA-CIN, Xenova
Click to Show/Hide
|
|||
| Indication | Cervical cancer [ICD-11: 2C77.0; ICD-9: 180] | Phase 2 | [1] | |
| Company |
Cantab Biopharmaceuticals Ltd; Xenova Group plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008671) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.